Lack of diversity in clinical trials undermines outcomes

07/9/2013 | PharmaTimes (U.K.)

Low participation of minority populations in clinical trials undermines the health care system, says Dr. Bruce Moskowitz, founder of Race and ethnicity may play a role in disease risk as well as drug response, but minorities remain underrepresented in clinical trials, Moskowitz says. Mistrust, lack of insurance, low awareness of clinical trial opportunities, language and health literacy barriers, eligibility criteria that exclude patients with multiple conditions, and other practical considerations keep many minorities from participating in clinical trials.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX